Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katja Seipel

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2015
Inactivation of the p53-KLF4-CEBPA Axis in Acute Myeloid LeukemiaKatja Seipel, Miguel Teixera Marques, Marie-Ange Bozzini, et al.
ACS Pharmacology & Translational Science|December 21, 2020
RNA Targeting in Acute Myeloid LeukemiaAlessandra Messikommer, Katja Seipel, Stephen Byrne, et al.
Journal of Clinical Medicine|March 29, 2023
BeEAM Conditioning including High-Dose Bendamustine before Autologous Stem Cell Transplantation Is Safe and Effective in Patients with Waldenstrom's MacroglobulinemiaAlexander D Heini, Philipp Beck, Ulrike Bacher, et al.
Hematological Oncology|June 16, 2016
Increased fibrinogen levels at diagnosis are associated with adverse outcome in patients with acute myeloid leukemiaMartin D Berger, Alexander D Heini, Katja Seipel, et al.
Biomedicines|February 27, 2026
Antibiotic Use Before CAR-T Treatment Is Associated with Inferior Outcomes in DLBCL Lymphoma PatientsAnja Bullegas, Inna Shaforostova, Katja Seipel, et al.
International Journal of Molecular Sciences|May 13, 2026
Analysis of Clinical Impact of CD33 rs12459419 Single-Nucleotide Polymorphism in AML Treated with Intensive Chemotherapy Without Gemtuzumab OzogamicinSophie Helfenstein, Inna Shaforostova, Katja Seipel, et al.
Leukemia Research|April 21, 2015
Neurotoxicity of stem cell mobilization chemotherapy with vinorelbine in myeloma patients after bortezomib treatmentSandra Keller, Katja Seipel, Urban Novak, et al.
Leukemia & Lymphoma|October 14, 2016
Cladribine, cytarabine and idarubicin (CLA-Ida) salvage chemotherapy in relapsed acute myeloid leukemia (AML)Chantal Fridle, Michael Medinger, Matthias C Wilk, et al.
Cancers|July 15, 2026
Low-Frequency <i>PPM1D</i> Gene Mutations Affect Treatment Response to BCMA-Targeted CAR T-Cell Therapy in Multiple MyelomaKatharina van der Weg, Martina Bertschinger, Ulrike Bacher, et al.
The International Journal of Developmental Biology|March 10, 2006
BMP2/4 and BMP5-8 in jellyfish development and transdifferentiationSusanne Reber-Müller, Ruth Streitwolf-Engel, Nathalie Yanze, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2015
Inactivation of the p53-KLF4-CEBPA Axis in Acute Myeloid LeukemiaKatja Seipel, Miguel Teixera Marques, Marie-Ange Bozzini, et al.
ACS Pharmacology & Translational Science|December 21, 2020
RNA Targeting in Acute Myeloid LeukemiaAlessandra Messikommer, Katja Seipel, Stephen Byrne, et al.
Journal of Clinical Medicine|March 29, 2023
BeEAM Conditioning including High-Dose Bendamustine before Autologous Stem Cell Transplantation Is Safe and Effective in Patients with Waldenstrom's MacroglobulinemiaAlexander D Heini, Philipp Beck, Ulrike Bacher, et al.
Hematological Oncology|June 16, 2016
Increased fibrinogen levels at diagnosis are associated with adverse outcome in patients with acute myeloid leukemiaMartin D Berger, Alexander D Heini, Katja Seipel, et al.
Biomedicines|February 27, 2026
Antibiotic Use Before CAR-T Treatment Is Associated with Inferior Outcomes in DLBCL Lymphoma PatientsAnja Bullegas, Inna Shaforostova, Katja Seipel, et al.
International Journal of Molecular Sciences|May 13, 2026
Analysis of Clinical Impact of CD33 rs12459419 Single-Nucleotide Polymorphism in AML Treated with Intensive Chemotherapy Without Gemtuzumab OzogamicinSophie Helfenstein, Inna Shaforostova, Katja Seipel, et al.
Leukemia Research|April 21, 2015
Neurotoxicity of stem cell mobilization chemotherapy with vinorelbine in myeloma patients after bortezomib treatmentSandra Keller, Katja Seipel, Urban Novak, et al.
Leukemia & Lymphoma|October 14, 2016
Cladribine, cytarabine and idarubicin (CLA-Ida) salvage chemotherapy in relapsed acute myeloid leukemia (AML)Chantal Fridle, Michael Medinger, Matthias C Wilk, et al.
Cancers|July 15, 2026
Low-Frequency <i>PPM1D</i> Gene Mutations Affect Treatment Response to BCMA-Targeted CAR T-Cell Therapy in Multiple MyelomaKatharina van der Weg, Martina Bertschinger, Ulrike Bacher, et al.
The International Journal of Developmental Biology|March 10, 2006
BMP2/4 and BMP5-8 in jellyfish development and transdifferentiationSusanne Reber-Müller, Ruth Streitwolf-Engel, Nathalie Yanze, et al.
Pageof 8